Healthcare

Global Epifluidic Diagnostics Technology Advancements and Growth Opportunities Updated Research Available

Disruptive technologies in flexible microfluidics and electronics are driving the development of next-generation devices

INDUSTRY
Healthcare

RELEASE DATE
26-Jul-2023
REGION
Global
DELIVERABLE TYPE
Technology Research

RESEARCH CODE
DAB3-01-00-00-00
SKU
TEMP_2023_30
Yes
SHARE

Global Epifluidic Diagnostics Technology Advancements and Growth Opportunities
Published on: 26-Jul-2023 | SKU: TEMP_2023_30

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Need more details?

This research service examines the advancements in epifluidic diagnostics technology, identifying the growth opportunities they present for the healthcare industry. Epifluidic diagnostics is an emerging class of wearable diagnostics that enables sweat and interstitial fluid (ISF) analysis through skin-interfaced microfluidic systems. These body-worn skin-conformable and flexible miniature devices with microelectronics, sensors, and flexible microfluidics allow long-term, painless, and continuous sampling of the alternate biofluids and real-time and continuous monitoring of diagnostic targets for precise health management. Technology advancements in this field, particularly the integration of artificial intelligence (AI) and machine learning (ML) solutions, help enable higher diagnostics accuracy and enhanced user convenience.
Researchers have found evidence that sweat- and ISF-based diagnostics can be used for a diverse range of applications, including viral infection detection, cystic fibrosis diagnosis, urea monitoring, and Parkinson's disease management. Sweat-based epifluidic diagnostics are predominantly utilized for hydration management and substance-use detection, while ISF-based epifluidic diagnostics are employed for metabolite measurement. Key players are actively expanding ISF-based epifluidic diagnostics for more clinical uses, such as therapeutic drug monitoring, cardiovascular disease monitoring, and sepsis detection. With several sectors of impact, epifluidic diagnostics has high market potential in the coming years.
The report takes a comprehensive look at the different types of epifluidic diagnostic technologies and their benefits and identifies the factors driving and restraining the growth of this market. It also identifies the key participants in the sweat-based epifluidic diagnostics and ISF-based epifluidic diagnostics segments, examining the technologies they employ, their target applications, and commercial readiness levels. The study covers regional and industry trends, including funding rounds, mergers and acquisitions (M&A), and patents filed. The base year is 2022, and the forecast period is 2023 to 2027.

Conventional diagnostics are performed in centralized laboratories involving painful sample collection, time-consuming and expensive logistics and long turnaround. Furthermore, due to the delay in the turnaround, the results indicate the health status of an individual several hours ago. 
Epifluidic diagnostics is an emerging class of wearable diagnostics that enable sweat or interstitial fluid analysis through skin-interfaced microfluidic systems. These body-worn skin-conformable and flexible miniature devices allow painless and continuous sampling of the alternate biofluids for long term and enables real-time and continuous monitoring of diagnostic targets for precise health management.
Sweat-based epifluidic diagnostics are predominantly utilized for hydration management and substance use detection, and interstitial fluid-epifluidic diagnostics are employed for metabolite measurement. Key players are actively expanding interstitial fluid-based epifluidic diagnostics for more clinical uses, such as therapeutic drug monitoring, cardiovascular disease monitoring and sepsis detection. Competitors are competing to provide critical applications, real-time insights, higher accuracy and enhanced user convenience.
Academic research groups have found evidences that sweat and interstitial fluid-based diagnostics can be used for a multitude of diverse applications, ranging from viral infection detection, cystic fibrosis diagnosis, urea monitoring to Parkinson's disease management. Therefore, with several sectors of impact, epifluidic diagnostics has a high market potential in the coming years.
Key players are integrating epifluidic diagnostic devices with advanced information and communication technologies, such as AI/ML algorithms. Therefore, it provides a growth opportunity for AI developers. The continuous health data from epifluidic diagnostic devices will also be valuable for digital twin technology developers.
The epifluidic diagnostic technologies, the benefits and their segments are detailed in the report. The drivers and restraints for the growth of the epifluidic diagnostics industry are explored. The participants in the sweat-based epifluidic diagnostics and interstitial fluid-based epifluidic diagnostics segments, the technologies they employ, their target applications and commercial readiness levels are discussed. The new applications emerging from the academic ecosystem have been explored in the report. The regional trends and development status of the epifluidic diagnostics segments for various applications, the funding, mergers and acquisitions (M&A) and the patent filing trend in the epifluidic diagnostics industry have been analyzed in detail. The growth opportunities for the epifluidic diagnostics industry have also been identified.

Why Is It Increasingly Difficult to Grow?The Strategic Imperative 8™: Factors Creating Pressure on Growth

The Strategic Imperative 8™

The Impact of the Top 3 Strategic Imperatives on the Epifluidic Diagnostics Industry

Growth Opportunities Fuel the Growth Pipeline Engine™

Research Methodology

Conventional Diagnostics and Epifluidic Diagnostics: A Comparison

Components of an Epifluidic Diagnostic Device and Emerging Innovations

Segmentation

Growth Drivers

Growth Restraints

Scope of Analysis

Overview

Competitive Environment

Competitive Environment (continued)

Competitive Environment (continued)

Competitive Environment (continued)

Emerging Sweat-sensing Applications from the Academic Innovation Ecosystem

Overview

Competitive Environment

Competitive Environment (continued)

Competitive Environment (continued)

Competitive Environment (continued)

Emerging ISF-sensing Applications from the Academic Innovation Ecosystem

Commercial Availability of Sweat- and ISF-based Epifluidic Diagnostics for Different Target Analytes

Epifluidic Diagnostics: Diverse Applications and Development Status

Technology Roadmap of Epifluidic Diagnostics

Regional Trends of Epifluidic Diagnostic Device Development

Analysis of M&As in the Epifluidic Diagnostics Industry, 2020–2023

Analysis of Government Funding for Epifluidic Diagnostics, 2020–2023

Snapshot of Private Funding for Epifluidic Diagnostics, 2020–2023

Snapshot of Private Funding for Epifluidic Diagnostics, 2020–2023 (continued)

IP Activity Analysis on Epifluidic Diagnostics (2018–2023)

Sweat-based Epifluidic Diagnostics—Innovation Themes Analysis (2018-2023)

ISF-based Epifluidic Diagnostics—Innovation Themes Analysis (2018–2023)

Growth Opportunity 1: Novel Microfluidic Systems Analyzing Alternate Sampleable Biofluids

Growth Opportunity 1: Novel Microfluidic Systems Analyzing Alternate Sampleable Biofluids (continued)

Growth Opportunity 2: IoT, AI/ML Algorithms, and Other Advanced Information and Communication Technologies

Growth Opportunity 2: IoT, AI/ML Algorithms, and Other Advanced Information and Communication Technologies (continued)

Growth Opportunity 3: Collaborations between Key Players, Academic Institutes, and Governments

Growth Opportunity 3: Collaborations between Key Players, Academic Institutes, and Governments (continued)

Technology Readiness Levels (TRL): Explanation

Patents

Your Next Steps

Why Frost, Why Now?

Legal Disclaimer


Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Healthcare research

17 Nov 2026   |   Global   |   Frost Radar

Frost Radar™: Quantum-Grade Sensor Technology Ecosystem for Healthcare Applications, 2026

Quantum-grade sensors are advancing healthcare by leveraging quantum phenomena to enable highly sensitive, precise, and non-invasive measurements of biological signals and physiological parameters. These innovations enhance diagnostic accuracy, disease monitoring, brain activity measurement, and ear...

16 Nov 2026   |   North America   |   Frost Radar

Frost Radar™: Healthcare Data Interoperability Platforms and Integration Engines in North America, 2026

This Frost Radar™ analyzes the healthcare data platform and integration engine vendors that enable healthcare organization to improve the exchange, utilization, contextualization, and management of clinical, operational, financial, and administrative data. Data issues, AI adoption, and solution gove...

03 Nov 2026   |   North America   |   Market Research

Enterprise Imaging Market, United States, 2025–2030

Enterprise imaging is no longer a technology upgrade. It is becoming the operating model for imaging across the provider organization, and the next investment cycle will decide which vendors lead it. This study gives vendors, ecosystem partners, and provider leaders a 360-degree view of that shift, ...

02 Nov 2026   |   Global   |   Market Research

Continuous Glucose Monitoring Market, Global, 2026

The global continuous glucose monitoring (CGM) market is undergoing a fundamental transformation as the technology evolves from a prescription-led glucose monitoring device into an AI-connected metabolic intelligence ecosystem. Market expansion is increasingly driven by the emergence of over-the-cou...

28 Oct 2026   |   Global   |   Frost Radar

Frost Radar™: Health Monitoring Wearable Solutions, 2026

The health monitoring wearables industry is undergoing a profound transformation as competitive advantage shifts from device hardware to integrated digital health ecosystems. Market leaders are differentiating through clinically validated health insights, longitudinal data platforms, AI-enabled anal...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.